Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Malreduction of tibial articular width in bicondylar tibial plateau fractures treated with circular external fixation is associated with post-traumatic osteoarthritis.

Thiagarajah S, Hancock GE, Mills EJ, McGregor-Riley JC, Royston SL, Dennison MG.

J Orthop. 2019 Jan 4;16(1):91-96. doi: 10.1016/j.jor.2018.12.016. eCollection 2019 Jan-Feb.

PMID:
30662246
2.

Accuracy and reliability of knee goniometry methods.

Hancock GE, Hepworth T, Wembridge K.

J Exp Orthop. 2018 Oct 19;5(1):46. doi: 10.1186/s40634-018-0161-5.

3.

Osteochondroma arising from a lumbar facet joint in a 16-year-old.

Hancock GE, Mariathas C, Fernandes JA, Breakwell LM, Cole AA, Michael AL.

J Pediatr Orthop B. 2015 May;24(3):251-4. doi: 10.1097/BPB.0000000000000115.

PMID:
25811920
4.

Management of splenic injury.

Hancock GE, Farquharson AL.

J R Army Med Corps. 2012 Dec;158(4):288-98. Review.

PMID:
23402064
5.

Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.

Elliott MB, Chen T, Terio NB, Chong SY, Abdullah R, Luckay A, Egan MA, Boutilier LA, Melville K, Lerch RA, Long D, Eldridge JH, Parks CL, Udem SA, Hancock GE.

Vaccine. 2007 Oct 10;25(41):7132-44. Epub 2007 Aug 21.

PMID:
17850933
6.

Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection.

Elliott MB, Welliver RC Sr, Laughlin TS, Pryharski KS, LaPierre NA, Chen T, Souza V, Terio NB, Hancock GE.

J Med Virol. 2007 Apr;79(4):447-56.

PMID:
17311330
7.

B-cell depletion inhibits arthritis in a collagen-induced arthritis (CIA) model, but does not adversely affect humoral responses in a respiratory syncytial virus (RSV) vaccination model.

Dunussi-Joannopoulos K, Hancock GE, Kunz A, Hegen M, Zhou XX, Sheppard BJ, Lamothe J, Li E, Ma HL, Hamann PR, Damle NK, Collins M.

Blood. 2005 Oct 1;106(7):2235-43. Epub 2005 Jun 9.

8.

Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein.

Elliott MB, Pryharski KS, Yu Q, Boutilier LA, Campeol N, Melville K, Laughlin TS, Gupta CK, Lerch RA, Randolph VB, LaPierre NA, Dack KM, Hancock GE.

J Virol. 2004 Aug;78(16):8446-54.

9.

Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro.

Elliott MB, Pryharski KS, Yu Q, Parks CL, Laughlin TS, Gupta CK, Lerch RA, Randolph VB, LaPierre NA, Dack KM, Hancock GE.

J Virol. 2004 Jun;78(11):5773-83.

10.

Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).

Elliott MB, Tebbey PW, Pryharski KS, Scheuer CA, Laughlin TS, Hancock GE.

J Med Virol. 2004 Jun;73(2):300-8.

PMID:
15122808
11.
12.
13.

Adaptive immune responses of patients with asthma to the attachment (G) glycoprotein of respiratory synctial virus.

Hancock GE, Scheuer CA, Sierzega R, Pryharski KS, McBride JT, Watelet LF, Tebbey PW, Smith JD.

J Infect Dis. 2001 Dec 15;184(12):1589-93.

PMID:
11776949
14.

CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV).

Hancock GE, Heers KM, Smith JD, Scheuer CA, Ibraghimov AR, Pryharski KS.

Vaccine. 2001 Sep 14;19(32):4874-82.

PMID:
11535341
16.

Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice.

van Schaik SM, Obot N, Enhorning G, Hintz K, Gross K, Hancock GE, Stack AM, Welliver RC.

J Med Virol. 2000 Oct;62(2):257-66.

PMID:
11002257
18.

Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.

Tebbey PW, Scheuer CA, Peek JA, Zhu D, LaPierre NA, Green BA, Phillips ED, Ibraghimov AR, Eldridge JH, Hancock GE.

Vaccine. 2000 Jun 1;18(24):2723-34.

PMID:
10781860
20.

A novel and effective intranasal immunization strategy for respiratory syncytial virus.

Tebbey PW, Unczur CA, LaPierre NA, Hancock GE.

Viral Immunol. 1999;12(1):41-5.

PMID:
10333241
22.
24.

The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virus.

Hancock GE, Hahn DJ, Speelman DJ, Hildreth SW, Pillai S, McQueen K.

Vaccine. 1994;12(3):267-74.

PMID:
8165859
25.

The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy.

Kaplan G, Britton WJ, Hancock GE, Theuvenet WJ, Smith KA, Job CK, Roche PW, Molloy A, Burkhardt R, Barker J, et al.

J Exp Med. 1991 Apr 1;173(4):993-1006.

26.

In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro.

Hancock GE, Molloy A, Ab BK, Kiessling R, Becx-Bleumink M, Cohn ZA, Kaplan G.

Cell Immunol. 1991 Feb;132(2):277-84.

PMID:
1988157
27.

Intradermal recombinant interleukin 2 enhances peripheral blood T-cell responses to mitogen and antigens in patients with lepromatous leprosy.

Converse P, Ottenhoff TH, Work Teklemariam S, Hancock GE, Dietz M, Becx-Bleumink M, Wondimu A, Kiessling R, Cohn ZA, Kaplan G.

Scand J Immunol. 1990 Aug;32(2):83-91.

PMID:
2389115
29.

Keratinocyte growth regulation by the products of immune cells.

Hancock GE, Kaplan G, Cohn ZA.

J Exp Med. 1988 Oct 1;168(4):1395-402.

30.

Multigenic control of resistance to Yersinia enterocolitica in inbred strains of mice.

Hancock GE, Schaedler RW, MacDonald TT.

Infect Immun. 1988 Feb;56(2):532-3.

31.

Yersinia enterocolitica infection in resistant and susceptible strains of mice.

Hancock GE, Schaedler RW, MacDonald TT.

Infect Immun. 1986 Jul;53(1):26-31.

32.

Trypanosomiasis in mice with naturally occurring immunodeficiencies.

Jones JF, Hancock GE.

Infect Immun. 1983 Nov;42(2):848-51.

Supplemental Content

Loading ...
Support Center